Price $23.65 |
Market Cap
197M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
13.6
|
P/B
3.13
|
P/S
3.16
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
11.3
|
Op. Cash Flow
21.8K
|
FCF
2.7
|
|
Op. Margin
33.20%
|
Net Margin
27.40%
|
ROE
30.30%
|
ROI
24.80%
|
|
ROA
26.30%
|
EPS Growth
8.50%
|
Current Ratio
7.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
